Clinical Trials Directory

Trials / Unknown

UnknownNCT04631627

Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort

A Prospective Muti-center Study of Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
1,500 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study intends to adopt the method of multi-center prospective randomized controlled study. The aim of this study is to obtain localized excision values through a preeclampsia screening model established in early pregnancy, and to evaluate the efficacy of low-dose aspirin intervention for preeclampsia prevention in pregnant women at high risk of screening.

Conditions

Interventions

TypeNameDescription
DRUGAspirinWith the result of risk assessment for high risk and the risk of pregnant women, with each research center stratified random aspirin drug intervention, for each center screening high-risk and accord with the standard drug intervention study phase into eliminate pregnant women by using stochastic indicator 1:1 randomly into low-dose aspirin to prevent group and observation group, for each center in screening for risk and comply with the drug intervention study phase into the exclusion standard 1:1 by random indicator method pregnant women randomly into low-dose aspirin to prevent group and observation group.

Timeline

Start date
2020-11-16
Primary completion
2021-12-30
Completion
2022-08-30
First posted
2020-11-17
Last updated
2020-11-17

Source: ClinicalTrials.gov record NCT04631627. Inclusion in this directory is not an endorsement.